Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Institut Bergonié
With
4 independant, multicenter, prospective, signle-arm phase II trials, based on 2-stage Simon's optimal design, will be conducted in parallel to assess the efficacy of durvalumab when prescribed with tazemetostat, separately, in distinct cohorts of solid tumors: * cohort A: patients with pancreatic cancer * cohort B: patients with colorectal cancer not MSI-H or MMR-deficient * cohort C: patients with metastatic solid tumors with positive interferon gamma signature and/or tertiary lymphoid structure positive * cohort D: patients with soft-tissue sarcoma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted